Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002206934 | SCV002369016 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2021-11-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003375572 | SCV004094438 | likely benign | Cardiovascular phenotype | 2023-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004704701 | SCV005207364 | likely benign | not provided | criteria provided, single submitter | not provided |